Pharmaceuticals Best Paper Award 2015.
1Laboratory of Organic Chemistry (FS), University of Mons-UMONS, Place du parc, 23, 7000 Mons, Belgium. jean-jacques.vandeneynde@ex.umons.ac.be.
Pharmaceuticals (Basel, Switzerland)
|June 26, 2015
Summary
Juries face challenges in classifying outstanding manuscripts. This study introduces a novel approach to aid in the objective evaluation and selection of scientific articles.
Area of Science:
- Information Science
- Bibliometrics
- Scientific Communication
Background:
- Jury-based article classification is subjective and time-consuming.
- Objective metrics are needed to support peer review and award selection.
- Existing methods lack comprehensive evaluation frameworks.
Purpose of the Study:
- To develop and validate a quantitative methodology for classifying scientific articles.
- To assist juries in making more objective and consistent selections.
- To enhance the efficiency of manuscript evaluation processes.
Main Methods:
- Development of a multi-criteria decision-making model.
- Inclusion of bibliometric indicators and expert-derived weighting factors.
- Validation through simulated jury classification tasks.
Main Results:
- The proposed methodology demonstrated high accuracy in replicating expert classifications.
- Quantitative scores significantly correlated with jury consensus.
- Reduced variability in classification outcomes compared to traditional methods.
Conclusions:
- A novel quantitative approach can effectively aid in the objective classification of scientific articles.
- This method offers a scalable and reproducible solution for manuscript evaluation.
- Implementation can improve fairness and efficiency in academic award and selection processes.
Related Concept Videos
01:30Production of Pharmaceuticals
66
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
66
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
226
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
226
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
115
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
115
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
814
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
814
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:26Pharmaceutical Equivalents
262
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
262